This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

20 Dec 2021

Moderna collaboration set to bring mRNA manufacturing to Australia

The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians

In a move to meet the challenges of the COVID-19 pandemic and future pathogens, Moderna has made an agreement in principle with the Australian Government to build a messenger RNA (mRNA) vaccine manufacturing facility in Victoria, Australia.

The facility is expected to produce up to 100 million vaccine doses each year, providing Australians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus (RSV) and potential other vaccines, pending licensure.

It will also be able to support Australia with direct access to rapid pandemic response capabilities, as well as access to Moderna’s vaccines in development for respiratory viruses.

Moderna's CEO Stéphane Bancel said the company believes this "sustainable national business model" will have "global impact and implications".

The company is discussing the potential of other collaborations built on a similar model with other governments.

Related News